{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-038544","form_type":"8-K/A","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.712407+00:00","generated_at":"2026-05-16T12:23:08.465599+00:00","sec_items":[],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cassava Sciences amends 8-K to report Dawn Bir appointed to Compensation Committee","bullets":["Dawn C. Bir appointed to Compensation Committee effective December 18, 2025.","Amendment to prior 8-K filed October 22, 2025 reporting her board appointment.","No other changes to the original current report."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-038544","json":"https://secwatch.observer/filing/0001437749-25-038544.json","markdown":"https://secwatch.observer/filing/0001437749-25-038544.md","text":"https://secwatch.observer/filing/0001437749-25-038544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925038544/0001437749-25-038544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925038544/sava20251219_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:23:08.465599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}